T8	Subject 0 40	Patients with previously untreated NSCLC
T10	Treatment 68 260	either tirapazamine (390 mg/m(2) infused over 2 hours) followed 1 hour later by cisplatin (75 mg/m(2) over 1 hour) or 75 mg/m(2) of cisplatin alone, every 3 weeks for a maximum of eight cycles
T14	Drug 75 87	tirapazamine
T15	Drug 148 157	cisplatin
T16	Dosage 89 100	390 mg/m(2)
T17	Route 101 108	infused
T18	Time_elapsed 109 121	over 2 hours
T19	Dosage 159 169	75 mg/m(2)
T20	Time_elapsed 170 181	over 1 hour
T22	Drug 200 209	cisplatin
T23	Dosage 186 196	75 mg/m(2)
T24	Freq 217 260	every 3 weeks for a maximum of eight cycles
T9	Potential_therapeutic_event 60 67	receive
T13	Combination 123 131	followed
E1	Potential_therapeutic_event:T9 
E2	Combination:T13 arg:T14 arg2:T15
T1	Treat-Disorder 35 40	NSCLC
